Patient Characteristics
Age | |
Median (range) in years | 40 (15-55) |
Sex | |
Male | 26 |
Female | 34 |
Diagnosis → BMT | |
Median (range) in months | 2.9 (0.2-69) |
Prior chemotherapy | |
Yes | 19 |
No | 41 |
Morphology-150 | |
RA/HMDS/RARS | 14 |
RAEB | 11 |
RAEBIT | 23 |
sAML | 12 |
Cytogenetic risk group-151 | |
Good | 25 |
Intermediate | 15 |
Poor | 17 |
Failed | 3 |
Age | |
Median (range) in years | 40 (15-55) |
Sex | |
Male | 26 |
Female | 34 |
Diagnosis → BMT | |
Median (range) in months | 2.9 (0.2-69) |
Prior chemotherapy | |
Yes | 19 |
No | 41 |
Morphology-150 | |
RA/HMDS/RARS | 14 |
RAEB | 11 |
RAEBIT | 23 |
sAML | 12 |
Cytogenetic risk group-151 | |
Good | 25 |
Intermediate | 15 |
Poor | 17 |
Failed | 3 |
Abbreviations: BMT, bone marrow transplantation; RA, refractory anemia; HMDS, hypoplastic myelodysplastic syndrome; RARS, refractory anemia with ringed sideroblasts; RAEB, refractory anemia with excess blasts; RAEBIT, refractory anemia with excess blasts in transformation; sAML, secondary acute myelogenous leukemia.
Classification based on highest bone marrow blast percentage before BMT.
As defined in text.